Correction to: Monoclonal Caveolin 1 Expression in the Differential Diagnosis of Malignant Pleural Mesothelioma and Pulmonary Adenocarcinoma: Is it Useful?

Correction to: Pathology & Oncology Research

Fig. 1
figure1

Cav-1 expression in MPM and PA cases; a: strong and score 3 (positivity in >50%of tumor cells) expression in epitheloidmesothelioma (×100), b: strong and score 3 expression in biphasic mesothelioma (×100), c: weak and score 2 (positivity in 11–50% of tumor cells) expression in sarcomatoid mesothelioma (×100), d: negative Cav-1 expression in epitheloid mesothelioma (×100), e: negative Cav-1 expression in biphasic mesothelioma (×100), f: negative Cav-1 expression in sarcomatoid mesothelioma (×100), g:Moderate and score (1 positivity in 1–10% of tumor cells) expression in PA (×100), h and i: negative Cav-1 expression in PA (×100)

https://doi.org/10.1007/s12253-019-00751-9

The original version of this article unfortunately contained an error in Fig. 1. Cav-1 expression in MPM and PA cases failed to show the histopathological details in Fig. 1 due to technical problem. The figure with the proper sharpness and clarity is shown in the next page.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Zehra Bozdag.

Additional information

The online version of the original article can be found at https://doi.org/10.1007/s12253-019-00751-9

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bozdag, Z., Tutar, E., Dizibuyuk, O.F. et al. Correction to: Monoclonal Caveolin 1 Expression in the Differential Diagnosis of Malignant Pleural Mesothelioma and Pulmonary Adenocarcinoma: Is it Useful?. Pathol. Oncol. Res. 26, 1657–1658 (2020). https://doi.org/10.1007/s12253-020-00793-4

Download citation